BNP Paribas Reiterates Outperform on Versigent, Lowers Price Target to $54
Benzinga Newsdesk 23 hours ago
Analyst RatingsNewsReiterationPrice Target
BNP Paribas analyst James Picariello reiterates Versigent (NYSE:VGNT) with a Outperform and lowers the price target from $55 to $54.
BNP Paribas analyst James Picariello reiterates Versigent (NYSE:VGNT) with a Outperform and lowers the price target from $55 to $54.